1- Molecular and Medicine Research Center, Arak University of Medical Sciences, Arak, Iran.; Department of Immunology, School of Medicine, Arak University of Medical Sciences, Arak, Iran.
2- Department of Immunology, School of Medicine, Arak University of Medical Sciences, Arak, Iran.
3- Traditional and Complementary Medicine Research Center (TCMRC), Arak University of Medical Sciences, Arak, Iran.
4- Molecular and Medicine Research Center, Arak University of Medical Sciences, Arak, Iran.; Department of Immunology, School of Medicine, Arak University of Medical Sciences, Arak, Iran. , gmosayebi@yahoo.com
Abstract: (3460 Views)
Cancer is one of the leading causes of death worldwide. Thus, it is important to find newer, more selective, and more effective therapies for this disease. One of these methods that have attracted many researchers is using anticancer peptides regarding their specificity, lower side effects, and higher effectiveness on the cancer cells. One type of anticancer peptides is antimicrobial peptides. Although they have already been studied and introduced as potential agents to fight infectious diseases, only recently they have been used as a new way of cancer treatment. For decades, antimicrobial peptides have been considered a component of the native immune system; however, they can also be used as anticancer peptides due to their mechanisms and properties. This new therapeutic approach can provide a promising pathway for optimal cancer treatment with fewer side effects.
Type of Study:
Review Article |
Subject:
Basic Sciences Received: 2018/11/4 | Accepted: 2019/03/12